deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06510426

Early Interferon-beta Treatment for West-Nile Virus Infection

Sponsor: Tel-Aviv Sourasky Medical Center

Conditions West Nile Fever Encephalitis West Nile Fever Myelitis West Nile Fever With Other Complications West Nile Virus
Interventions Rebif 44 MCG Per 0.5 ML Prefilled Syringe Saline
Updated 3 times since 2024 Last updated: Jul 20, 2024 Started: Jul 14, 2024 Primary completion: Jul 14, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates West Nile Fever Encephalitis and West Nile Fever Myelitis and is currently actively recruiting participants. Tel-Aviv Sourasky Medical Center leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE2

  3. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tel-Aviv Sourasky Medical Center
Data source: Tel-Aviv Sourasky Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations